STAGE III PRIMARY PERITONEAL CANCER AJCC V8
Clinical trials for STAGE III PRIMARY PERITONEAL CANCER AJCC V8 explained in plain language.
Never miss a new study
Get alerted when new STAGE III PRIMARY PERITONEAL CANCER AJCC V8 trials appear
Sign up with your email to follow new studies for STAGE III PRIMARY PERITONEAL CANCER AJCC V8, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
Trial tests gentler hormone pill against harsh chemo for rare ovarian cancer
Disease control OngoingThis study aims to find out if a daily hormone pill (letrozole) works as well as or better than standard chemotherapy (paclitaxel/carboplatin) followed by the same pill for patients with advanced low-grade ovarian, fallopian tube, or peritoneal cancer. It involves 450 women who h…
Matched conditions: STAGE III PRIMARY PERITONEAL CANCER AJCC V8
Phase: PHASE3 • Sponsor: NRG Oncology • Aim: Disease control
Last updated Apr 01, 2026 14:42 UTC
-
New hope for Hard-to-Treat ovarian cancer? early trial tests drug combo
Disease control OngoingThis early-stage study is testing the safety and best dose of a new drug called ipatasertib when given alongside standard chemotherapy drugs (paclitaxel and carboplatin) to patients with advanced ovarian, fallopian tube, or primary peritoneal cancer. The goal is to see if adding …
Matched conditions: STAGE III PRIMARY PERITONEAL CANCER AJCC V8
Phase: PHASE1 • Sponsor: National Cancer Institute (NCI) • Aim: Disease control
Last updated Mar 30, 2026 14:35 UTC
-
Double attack on tough cancers: early trial tests combo for patients out of options
Disease control OngoingThis early-stage trial is testing a combination of two drugs, niraparib and dostarlimab, for people with advanced breast, ovarian, pancreatic, or related cancers that have a specific genetic change (BRCA mutation) and have stopped responding to standard treatments. The goal is to…
Matched conditions: STAGE III PRIMARY PERITONEAL CANCER AJCC V8
Phase: PHASE1 • Sponsor: University of Washington • Aim: Disease control
Last updated Mar 23, 2026 15:16 UTC
-
New hope: testing targeted drug before surgery for aggressive ovarian cancer
Disease control OngoingThis early study is testing whether a drug called olaparib can help shrink tumors before surgery in people newly diagnosed with advanced ovarian cancer that has a BRCA gene mutation. The trial involves about 15 participants who will take olaparib pills for up to two months before…
Matched conditions: STAGE III PRIMARY PERITONEAL CANCER AJCC V8
Phase: EARLY_PHASE1 • Sponsor: M.D. Anderson Cancer Center • Aim: Disease control
Last updated Mar 20, 2026 14:47 UTC